Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer - Clinical examination, mammography, or magnetic resonance imaging?

Journal of Surgical Oncology

Volumn 101, Issue 7, 2010, Pages 604-610

  Wright, F C ^a   Zubovits, J ^a   Gardner, S ^b   Fitzgerald, B ^b   Clemons, M ^c   Quan, M L ^a   Causer, P ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Imaging; Locally advanced breast cancer; Magnetic resonance imaging; Neo adjuvant chemotherapy; Residual disease

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; TRASTUZUMAB;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCALLY ADVANCED AND INFLAMMATORY BREAST CANCER; MAMMOGRAPHY; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; DECISION MAKING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PALPATION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77952054738     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21559     Document Type: Article

References (29)

1. Lee MC, Newman LA: Management of patients with locally advanced breast cancer. Surg Clin North Am 2007;87:379-398.
2. Chia S, Swain SM, Byrd DR, et al.: Locally advanced and inflammatory breast cancer. J Clin Oncol 2008;26:786-790.
3. Fisher B, Brown A, Mamounas E, et al.: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483-2493.
4. Singletary SE, McNeese MD, Hortobagyi GN: Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 1992;69:2849-2852.
5. Cance WG, Carey LA, Calvo BF, et al.: Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: Effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 2002;236:295-302.
6. Danforth DN, Jr., Zujewski J, O'Shaughnessy J, et al.: Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA, B breast cancer. Ann Surg Oncol 1998;5:150-158.
7. Garimella V, Qutob O, Fox JN, et al.: Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients. Eur J Surg Oncol 2007;33:157-161.
8. Schwartz GF, Birchansky CA, Komarnicky LT, et al.: Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362-369.
9. Kwong MS, Chung GG, Horvath LJ, et al.: Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer. Cancer J 2006;12:212-221.
10. Rajan R, Poniecka A, Smith TL, et al.: Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response. Cancer 2004;100:1365-1373.
11. Schott AF, Roubidoux MA, Helvie MA, et al.: Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005;92:231-238.
12. Warren RM, Bobrow LG, Earl HM, et al.: Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 2004;90:1349-1360.
13. Rosen EL, Blackwell KL, Baker JA, et al.: Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol 2003;181:1275-1282.
14. Thibault F, Nos C, Meunier M, et al.: MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy. Am J Roentgenol 2004;183:1159-1168.
15. Rieber A, Brambs HJ, Gabelmann A, et al.: Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002;12:1711-1719.
16. Singletary SE, Allred C, Ashley P, et al.: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628-3636.
17. American College of Radiology. American College of Radiology (ACR) reporting system, in Breast Imaging Reporting and Data System (BI-RADS), 2nd edition. Reston, VA: American College of Radiology; 1993. pp. 15-18.
18. Ogston KN, Miller ID, Payne S, et al.: A new histological grading system to assess response of breast cancers to primary chemotherapy: Prognostic significance and survival. Breast 2003;12:320-327.
19. Padhani AR, Ollivier L: The RECIST (response evaluation criteria in solid tumors) criteria: Implications for diagnostic radiologists. Br J Radiol 2001;74:983-986.
20. Therasse P, Arbuck SG, Eisenhauer EA, et al.: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
21. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
22. Julius T, Kemp SE, Kneeshaw PJ, et al.: MRI and conservative treatment of locally advanced breast cancer. Eur J Surg Oncol 2005;31:1129-1134.
23. Chen AM, Meric-Bernstam F, Hunt KK, et al.: Breast conservation after neoadjuvant chemotherapy. Cancer 2005;103:689-695.
24. Cheung YC, Chen SC, Su MY, et al.: Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat 2003;78:51-58.
25. Londero V, Bazzocchi M, Del Frate C, et al.: Locally advanced breast cancer: Comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004;14:1371-1379.
26. Herrada J, Iyer RB, Atkinson EN, et al.: Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 1997;3:1565-1569. (Pubitemid 27431564)
27. Trecate G, Ceglia E, Stabile F, et al.: Locally advanced breast cancer treated with primary chemotherapy: Comparison between magnetic resonance imaging and pathologic evaluation of residual disease. Tumori 1999;85:220-228. (Pubitemid 29482205)
28. Rastogi P, Anderson SJ, Bear HD, et al.: Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.[erratum appears in J Clin Oncol. 2008 Jun 1; 26(16):2793]. J Clin Oncol 2008;26:778-785.
29. Kuerer HM, Newman LA, Smith TL, et al.: Clinical course of breast cancer patients with complete pathologic primary tumorand axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 1999;17:460-469.